Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.25
Bid: 9.50
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.50 (15.789%)
Open: 10.25
High: 10.40
Low: 10.00
Prev. Close: 10.25
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: PetroNeft extends maturity; NetScientific loses chair

Wed, 01st Feb 2023 21:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

NetScientific PLC - life sciences and sustainability technology investment firm - Reports that John Clarkson has stepped down as chair and resigned from the board with immediate effect. Says that Non-Executive Director Jonathan Robinson will now become interim non-executive chair while the company completes its recruitment process to appoint a new chair.

----------

PetroNeft Resources PLC - Ireland-based, Russian-focused oil and gas exploration and production company - Extends the maturity date for its loan facility to March 15. The loan facility has a current redemption value of USD2.5 million, it adds. Cash and cash equivalents for PetroNeft Group stand at USD439,566 as at January 31.

----------

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Appoints Jean-Michel Cossery as chair with immediate effect. Says that he has over 25 years of experience in the pharmaceutical and biotechnology industries.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
18 May 2016 08:06

Scancell Shuffles Board As New US Offices Open, Plans For Oxford Base

Read more
4 Apr 2016 11:47

Scancell raises £6.2m in placing and open offer

(ShareCast News) - Scancell revealed the final results of its placing and open offer on Monday, with a few more subscriptions received since the firm's last update on 1 April. The AIM-traded company had announced on Friday that it had received subscriptions for 16,048,593 new ordinary shares of the

Read more
4 Apr 2016 09:31

Scancell Raises Further Funding Through Open Offer (ALLISS)

Read more
1 Apr 2016 11:27

CORRECT: Scancell Raises Funds In Placing, Open Offer (ALLISS)

Read more
1 Apr 2016 09:06

Scancell Raises Total Of GBP6.1 Million In Placing, Open Offer (ALLISS)

Read more
11 Mar 2016 08:51

Scancell skips higher on Swedish research collaboration

(ShareCast News) - Immuno-oncology specialist Scancell has impressed investors with a new research partnership with Sweden's Karolinska Institutet into the role of citrullinated proteins in the treatment of cancer. Both parties have uncovered important roles that citrullinated proteins can play in h

Read more
11 Mar 2016 08:01

Scancell Signs Strategic Research Agreement With Karolinska Institutet

Read more
9 Mar 2016 16:25

CORRECT: UPDATE: Scancell Holdings Raises GBP3.4 Million (ALLISS)

Read more
9 Mar 2016 14:28

UPDATE: Scancell Holdings Raises GBP7.2 Million To Back Pipeline (ALLISS)

Read more
9 Mar 2016 09:57

Scancell Holdings Plans To Raise GBP6.8 Million To Back Pipeline (ALLISS)

Read more
27 Jan 2016 10:43

Scancell Pretax Loss Narrows As Development Of Treatments Continues

Read more
11 Jan 2016 08:18

Scancell Holdings Gets Good Results From SCIB1 Cancer Trials

Read more
7 Jan 2016 08:32

Scancell Appoints New Chairman To Lead US Market Push

Read more
5 Jan 2016 08:16

Scancell Welcomes Supportive Paper In Cancer Research Journal

Read more
18 Dec 2015 10:49

Scancell To Undertake Phase II Study Of Cancer Vaccine SCIB1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.